Detalles de la búsqueda
1.
Piperacillin/tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing.
Clin Infect Dis
; 2024 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38902929
2.
In vitro development of resistance against antipseudomonal agents: comparison of novel ß-lactam/ß-lactamase inhibitor combinations and other ß-lactam agents.
Antimicrob Agents Chemother
; 68(5): e0136323, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38526050
3.
7-Year (2015-21) longitudinal surveillance of lefamulin in vitro activity against bacterial pathogens collected worldwide from patients with respiratory tract infections including pneumonia and characterization of resistance mechanisms.
J Antimicrob Chemother
; 79(2): 360-369, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38113528
4.
Determination of MIC Quality Control Ranges for Ceftibuten-Avibactam (Fixed 4 µg/mL), a Novel ß-Lactam/ß-Lactamase Inhibitor Combination.
J Clin Microbiol
; 61(7): e0165722, 2023 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37395644
5.
Antimicrobial activity of ceftibuten-avibactam against a global collection of Enterobacterales from patients with urinary tract infections (2021).
Eur J Clin Microbiol Infect Dis
; 42(4): 453-459, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36810724
6.
In Vitro Potency and Spectrum of the Novel Polymyxin MRX-8 Tested against Clinical Isolates of Gram-Negative Bacteria.
Antimicrob Agents Chemother
; 66(5): e0013922, 2022 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35475635
7.
Activity of Oritavancin against Gram-Positive Pathogens Causing Bloodstream Infections in the United States over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010-2019).
Antimicrob Agents Chemother
; 66(2): e0166721, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34807761
8.
Antimicrobial activity of cefepime/zidebactam (WCK 5222), a ß-lactam/ß-lactam enhancer combination, against clinical isolates of Gram-negative bacteria collected worldwide (2018-19).
J Antimicrob Chemother
; 77(10): 2642-2649, 2022 09 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35897129
9.
Comparative activity of newer ß-lactam/ß-lactamase inhibitor combinations against Pseudomonas aeruginosa from patients hospitalized with pneumonia in European medical centers in 2020.
Eur J Clin Microbiol Infect Dis
; 41(2): 319-324, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34657213
10.
Antimicrobial activity of dalbavancin against Gram-positive bacteria isolated from patients hospitalized with bloodstream infection in United States and European medical centers (2018-2020).
Eur J Clin Microbiol Infect Dis
; 41(5): 867-873, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35355158
11.
Antimicrobial activities of aztreonam-avibactam and comparator agents tested against Enterobacterales from European hospitals analysed by geographic region and infection type (2019-2020).
Eur J Clin Microbiol Infect Dis
; 41(3): 477-487, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35041100
12.
Increasing frequency of OXA-48-producing Enterobacterales worldwide and activity of ceftazidime/avibactam, meropenem/vaborbactam and comparators against these isolates.
J Antimicrob Chemother
; 76(12): 3125-3134, 2021 11 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34459890
13.
Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019.
J Antimicrob Chemother
; 76(3): 659-666, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33276387
14.
Investigation of mechanisms responsible for decreased susceptibility of aztreonam/avibactam activity in clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019.
J Antimicrob Chemother
; 76(11): 2833-2838, 2021 10 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34436603
15.
In Vitro Activity and Potency of the Novel Oxazolidinone Contezolid (MRX-I) Tested against Gram-Positive Clinical Isolates from the United States and Europe.
Antimicrob Agents Chemother
; 64(11)2020 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32778552
16.
Antimicrobial Activity of Ceftolozane-Tazobactam and Comparators against Clinical Isolates of Haemophilus influenzae from the United States and Europe.
Antimicrob Agents Chemother
; 64(5)2020 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32094135
17.
Activity of Plazomicin Tested against Enterobacterales Isolates Collected from U.S. Hospitals in 2016-2017: Effect of Different Breakpoint Criteria on Susceptibility Rates among Aminoglycosides.
Antimicrob Agents Chemother
; 64(5)2020 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32094137
18.
Activity of Meropenem-Vaborbactam against Bacterial Isolates Causing Pneumonia in Patients in U.S. Hospitals during 2014 to 2018.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31907187
19.
Antimicrobial Activity of Aztreonam-Avibactam and Comparator Agents When Tested against a Large Collection of Contemporary Stenotrophomonas maltophilia Isolates from Medical Centers Worldwide.
Antimicrob Agents Chemother
; 64(11)2020 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32900683
20.
Assessment of Tedizolid In Vitro Activity and Resistance Mechanisms against a Collection of Enterococcus spp. Causing Invasive Infections, Including Isolates Requiring an Optimized Dosing Strategy for Daptomycin from U.S. and European Medical Centers, 2016 to 2018.
Antimicrob Agents Chemother
; 64(4)2020 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32015026